Purpose of this Study
We are doing this study to help create a national biobank of samples and data about patients who experience side effects when they take immunotherapy drugs for their cancer. We want to find out why some people experience side effects and why others do not. We also want to learn more about how to diagnose and treat these side effects more effectively.
Who Can Participate?
Eligibility
Adults ages 18+ who:
- Are diagnosed with cancer and have not previously been treated with CTLA-4, PD-1, or PD-L1 inhibitors
- Received a regimen containing one or more immuno-oncology therapeutics
- Experienced one or more serious AEs during treatment
- Have not previously been registered to this study
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
You can choose to join this study if you are receiving immunotherapy as part of your cancer treatment. You may enroll before or after experiencing one or more side effects.
Locations
Duke Raleigh Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
Alliance A151804 Establishment of a national biorepository to advance studies of immune-related adverse events
Principal Investigator
Tucker
Coston
Protocol Number
PRO00117018
NCT ID
NCT04242095
Phase
N/A
Enrollment Status
Open to Enrollment